Table 2.
Definitions of Clinical Measurements of Interest Obtained From the Segmentations
| Imaging Modality | Biomarker | Definition | Measurements of Interest |
|---|---|---|---|
| ICGA | Polypoidal lesions | As segmented | Area |
| BVN | As segmented | Area | |
| SD-OCT | Retina | ILM–BM layers | Volume, average height |
| Choroid | BM–CSI layers | Volume, average height | |
| SIRE | RPE–BM layer thickness > 15 μm or RPE layer roughness > 2 μm (within window of 400 μm length) | Volume, average height | |
| PED | RPE–BM layer thickness > 150 μm | Volume, maximum height | |
| EZ defects | Absence of EZ | Area | |
| IRF | As segmented | Volume, average height | |
| SRF | As segmented | Volume, average height | |
| Sub-RPE ring-like lesions | As segmented | Volume, average height |
BM = Bruch’s membrane; BVN = branching vascular network; CSI = choroidal-scleral interface; EZ = ellipsoid zone; ICGA = indocyanine green angiography; ILM = inner limiting membrane; IRF = intraretinal fluid; PCV = polypoidal choroidal vasculopathy; PED = pigment epithelium detachment; RPE = retinal pigment epithelium; SD = spectral domain; SIRE = shallow irregular RPE elevation; SRF = subretinal fluid.